M&A Deal Summary

Wright Medical Group Acquires BioMimetic Therapeutics

On March 1, 2013, Wright Medical Group acquired life science company BioMimetic Therapeutics for 190M USD

Acquisition Highlights
  • This is Wright Medical Group’s 1st transaction in the Life Science sector.
  • This is Wright Medical Group’s largest (disclosed) transaction.
  • This is Wright Medical Group’s 5th transaction in the United States.
  • This is Wright Medical Group’s 1st transaction in Tennessee.

M&A Deal Summary

Date 2013-03-01
Target BioMimetic Therapeutics
Sector Life Science
Buyer(s) Wright Medical Group
Deal Type Add-on Acquisition
Deal Value 190M USD

Target

BioMimetic Therapeutics

Franklin, Tennessee, United States
website
BioMimetic Therapeutics, Inc. is a biotechnology company.

Search 193,502 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Wright Medical Group

Arlington, Tennessee, United States

Category Company
Founded 1950
Sector Medical Products
Employees898
Revenue 242M USD (2013)
DESCRIPTION

Wright Medical Group, Inc. is an orthopedic medical device company specializing in the development and marketing of reconstructive joint devices and bio-orthopedics.


DEAL STATS #
Overall 5 of 8
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 4 of 7
State (Tennessee) 1 of 2
Country (United States) 5 of 7
Year (2013) 1 of 2
Size (of disclosed) 1 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-04-02 INBONE Technologies

Berkeley, California, United States

INBONE Technologies, Inc. is a manufacturer of INBONE Total Ankle System and the INBONE Intra-osseous Fusion Rod and Plate System.

Buy $24M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-10-16 Biotech International SARL

Salon de Provence, France

Biotech International SARL is a manufacturer that specializes in the design, production and marketing of surgical implants and advanced fixation technologies for the Extremities market.

Buy $80M